Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001610717-24-000399
Filing Date
2024-07-17
Accepted
2024-07-17 20:35:22
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3801
  Complete submission text file 0001610717-24-000399.txt   5352
Mailing Address 10940 WILSHIRE BLVD. SUITE 600 LOS ANGELES CA 90024
Business Address
AUERBACH ALAN H (Reporting) CIK: 0001358285 (see all company filings)

Type: 144

Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Subject) CIK: 0001401667 (see all company filings)

EIN.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-35703 | Film No.: 241123512
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)